Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 207Observational 3

Sponsor

Cancer Type

Breast 11Gastrointestinal 6Lymphoid 4Sarcoma 3Gynecologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1CNS 1

Conditions

Sarcoma 1Osteosarcoma 1Desmoid Tumors 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Doxorubicin × Sarcoma × Clear all
NCT04055753 2026-05-22

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Fox Chase Cancer Center

Active not recruiting
24 enrolled
Sarcoma

Sarcoma

NCT06268457 2026-05-14

Embodesmo

Istituto Ortopedico Rizzoli

Recruiting
20 enrolled
Sarcoma

Desmoid Tumors

NCT02986503 2016-12-08

EUROBOSS

Italian Sarcoma Group

Completed
100 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡